FORUM MARKETS Inc current report, Q3 FY2025

Full document

Business Context and Reporting Period

Company: ETHZilla Corporation (formerly 180 Life Sciences Corp.)
Filing Type: Form 8-K (Current Report)
Date of Report: September 22, 2025
Business Overview: The Company is engaged in the accumulation of Ether (ETH) and related digital assets. This filing reports the entry into a material definitive agreement involving a new debt financing and amendments to existing debt terms.

Key Financial Metrics and Transaction Details

New Debt Financing

  • Instrument: Senior Secured Convertible Notes ("New Convertible Notes").
  • Principal Amount: $350,000,000.
  • Cash Proceeds: 97.25% of principal (approximately $340.375 million).
  • Interest Rate: 2.00% per annum (increases to 18.00% upon an event of default).
  • Maturity Date: August 8, 2028.
  • Collateral: Secured by $50 million of Ether (ETH) and approximately $500 million in cash.
  • Conversion Price: Initial price of $3.05 per share, subject to downward-only resets.
  • Exchange Cap: Conversion limited to 19.99% of outstanding shares without stockholder approval.

Amendment to Existing Debt

  • Existing Notes: $156,250,000 principal amount issued in August 2025.
  • Interest Rate Reduction: Reduced from 4% to 2%.
  • Conversion Price Adjustment: Automatically adjusted to match the New Convertible Notes price of $3.05.
  • Operational Flexibility: Company permitted to stake collateral ETH and use yield from cash collateral (less accrued interest) for ordinary business operations.

Asset and Liquidity Position (as of September 19, 2025)

  • Total ETH & Equivalents: 102,264 units (approx. $462 million).
  • Total USD Cash Equivalents: Approximately $559 million.
  • Total Earned Protocol Tokens: 1,500,000.
  • Shares Outstanding: 160,176,122.

Material Changes and Strategic Actions

Stock Repurchase Program

  • Authorization: Board approved a $250.0 million repurchase program on August 22, 2025.
  • Expiration: June 30, 2026, or upon completion of the $250 million limit.
  • Recent Activity: Between September 13 and September 19, 2025, the Company repurchased approximately 0.5 million shares at an average price of $2.41 per share.

Future Equity Issuance Rights

The Amendment Agreement permits the Company to conduct additional equity placements (excluding variable rate transactions) with gross proceeds up to $1 billion within 90 days of the resale registration statement effectiveness, or at any time if the purchase price exceeds $4.00 per share.

Financial Obligations and Covenants

  • Redemption Rights: Investor may require redemption if the loan-to-value ratio exceeds 85% or upon a Trigger Event. Investor may also require redemption after May 8, 2026.
  • Mandatory Conversion: Company may force conversion after March 22, 2026, if the 30-day VWAP exceeds $4.4785 and equity conditions are met.
  • Covenants: Must maintain at least $5 million in non-controlled accounts and a loan-to-value ratio of no more than 100%.

Risks, Contingencies, and Management Commentary

  • Dilution Risk: Full conversion of the $350 million New Convertible Notes at $3.05 could result in the issuance of approximately 114.75 million shares, representing significant dilution to existing shareholders.
  • Asset Security Risk: The notes are secured by a significant portion of the Company's assets ($50M ETH and $500M cash). In the event of default, the investor may enforce security interests, potentially taking control of assets and operations.
  • Operational Restrictions: Covenants limit the Company's ability to issue additional dilutive securities or pursue certain strategic opportunities without investor consent.
  • Forward-Looking Statements: Management notes that actual results regarding stock repurchases and use of proceeds may differ materially from expectations due to market conditions and covenant compliance.

Key Facts for Investor Verification

  • Verify the current market price of ETH and the Company's total collateral value to assess the loan-to-value ratio relative to the 85% and 100% covenant thresholds.
  • Confirm the status of the resale registration statement required for the conversion of the New Convertible Notes.
  • Monitor the Company's stock price relative to the $3.05 conversion price and the $4.4785 mandatory conversion trigger.
  • Review the specific terms of the "Trigger Event" and "Equity Conditions" defined in the New Convertible Notes to understand redemption and conversion risks.
  • Track the remaining capacity of the $250 million stock repurchase program and the Company's cash burn rate versus the yield generated from staked assets.